Paul M Ridker, MD, MPH
Paul M Ridker, MD, MPH
Eugene Braunwald Professor of Medicine, Harvard Medical School
Geverifieerd e-mailadres voor partners.org
Titel
Geciteerd door
Geciteerd door
Jaar
Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
25247*2014
Inflammation and atherosclerosis
P Libby, PM Ridker, A Maseri
Circulation 105 (9), 1135-1143, 2002
204612002
Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
Circulation 131 (4), 434-441, 2015
155582015
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
Antithrombotic Trialists' Collaboration
Bmj 324 (7329), 71-86, 2002
12028*2002
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker, CH Hennekens, JE Buring, N Rifai
New England journal of medicine 342 (12), 836-843, 2000
76752000
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
PM Ridker, M Cushman, MJ Stampfer, RP Tracy, CH Hennekens
New England journal of medicine 336 (14), 973-979, 1997
72131997
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
PM Ridker, E Danielson, FAH Fonseca, J Genest, AM Gotto Jr, ...
New England journal of medicine 359 (21), 2195-2207, 2008
71672008
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
M Flather
The Lancet 376 (9753), 1670-1681, 2010
5651*2010
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan, JAE Manson, N Rifai, JE Buring, PM Ridker
Jama 286 (3), 327-334, 2001
51572001
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
PM Ridker, N Rifai, L Rose, JE Buring, NR Cook
New England journal of medicine 347 (20), 1557-1565, 2002
48112002
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I
M Naghavi, P Libby, E Falk, SW Casscells, S Litovsky, J Rumberger, ...
Circulation 108 (14), 1664-1672, 2003
42342003
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
J Danesh, JG Wheeler, GM Hirschfield, S Eda, G Eiriksdottir, A Rumley, ...
New England Journal of Medicine 350 (14), 1387-1397, 2004
37832004
Long-term effects of pravastatin on plasma concentration of C-reactive protein
PM Ridker, N Rifai, MA Pfeffer, F Sacks, E Braunwald
Circulation 100 (3), 230-235, 1999
3471*1999
Antiinflammatory therapy with canakinumab for atherosclerotic disease
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
34682017
Progress and challenges in translating the biology of atherosclerosis
P Libby, PM Ridker, GK Hansson
Nature 473 (7347), 317-325, 2011
33922011
Biological, clinical and population relevance of 95 loci for blood lipids
TM Teslovich, K Musunuru, AV Smith, AC Edmondson, IM Stylianou, ...
Nature 466 (7307), 707-713, 2010
32652010
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
PM Ridker
Circulation 107 (3), 363-369, 2003
31762003
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women
PM Ridker, JE Buring, NR Cook, N Rifai
Circulation 107 (3), 391-397, 2003
30612003
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
PM Ridker, N Rifai, MJ Stampfer, CH Hennekens
Circulation 101 (15), 1767-1772, 2000
30082000
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
MA Pfeffer, JJV McMurray, EJ Velazquez, JL Rouleau, L KÝber, ...
New England Journal of Medicine 349 (20), 1893-1906, 2003
29712003
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20